Escherichia coli is the predominant nonpathogenic facultative flora of the human intestine.
Some E. coli strains, however, have developed the ability to cause disease of the …

Most cases of diarrhoea-associated haemolytic uraemic syndrome (HUS) are caused by
Shiga-toxin-producing bacteria; the pathophysiology differs from that of thrombotic …

In 1982, investigation of two outbreaks of a distinctive bloody diarrheal syndrome led to the
identification of a new bacterial pathogen, Escherichia coli O157: H7 (1). In the decade …

Since their initial recognition 20 years ago, Shiga toxin-producing Escherichia coli (STEC)
strains have emerged as an important cause of serious human gastrointestinal disease …

The widening array of recognized enteric pathogens and the increasing demand for cost-
containment sharpen the need for careful clinical and public health guidelines based on the …

Background Children with gastrointestinal infections caused by Escherichia coli O157: H7
are at risk for the hemolytic–uremic syndrome. Whether antibiotics alter this risk is unknown …

Escherichia coli O157 was first identified as a human pathogen in 1982. One of several
Shiga toxin-producing serotypes known to cause human illness, the organism probably …

Background. Antibiotic administration to individuals with Shiga toxin–producing Escherichia
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …

In 1930, Felix d'Herelle wrote “... the actions and reactions are not solely between these two
beings, man and bacterium, for the bacteriophage also intervenes; a third living being and …

Shiga toxin-producing Escherichia coli (STEC) cause significant disease; treatment is
supportive and antibiotic use is controversial. Ciprofloxacin but not fosfomycin causes Shiga …